| Literature DB >> 34803519 |
Siqi Deng1, Shijie Shen1, Saeed El-Ashram2,3, Huan Lu1, Dan Luo1, Guomin Ye1, Bo Zhang1, Hui Zhang1, Wanjiang Zhang1, Jiangdong Wu1, Chuangfu Chen1.
Abstract
Tuberculosis (TB) is the world's most prevalently infectious disease. Molecular mechanisms behind tuberculosis remain unknown. microRNA (miRNA) is involved in a wide variety of diseases. To validate the significant genes and miRNAs in the current sample, two messenger RNA (mRNA) expression profile datasets and three miRNA expression profile datasets were downloaded from the Gene Expression Omnibus (GEO) database. The differentially expressed (DE) genes (DEGs) and miRNAs (DE miRNAs) between healthy and TB patients were filtered out. Enrichment analysis was executed, and a protein-protein interaction (PPI) network was developed to understand the enrich pathways and hub genes of TB. Additionally, the target genes of miRNA were predicted and overlapping target genes were identified. We studied a total of 181 DEGs (135 downregulated and 46 upregulated genes) and two DE miRNAs (2 downregulated miRNAs) from two gene profile datasets and three miRNA profile datasets, respectively. 10 hub genes were defined based on high degree of connectivity. A PPI network's top module was constructed. The 23 DEGs identified have a significant relationship with miRNAs. 25 critically significant Gene ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathways were discovered. The detailed study revealed that, in tuberculosis, the DE miRNA and DEGs form an interaction network. The identification of novel target genes and main pathways would aid with our understanding of miRNA's function in tuberculosis progression.Entities:
Mesh:
Substances:
Year: 2021 PMID: 34803519 PMCID: PMC8572619 DOI: 10.1155/2021/6226291
Source DB: PubMed Journal: Genet Res (Camb) ISSN: 0016-6723 Impact factor: 1.588
Figure 1Flow diagram of bioinformatics analysis.
Figure 2(a) Volcano plot showing downregulated and upregulated differentially expressed genes. (b) Venn diagram displaying the number of common differentially expressed genes (DEGs) between normal people and patients with TB. (c) Venn diagram for common differentially expressed miRNA (DE miRNA).
Differentially expressed genes between the normal people and patients with TB.
| Regulations | DEGs |
|---|---|
| Upregulated | LHFPL2, ANXA3, F2RL1, PPM1A, VWCE, LAMTOR3, SECTM1, GYPA, SNCA, TDRD9, WDR26, ALPK1, CR1, RMND5A, FAM8A1, OLFM4, ACSL1, GPR84, MBNL3, ARG2, PPP4R2, HIST1H3D, CLEC5A, STAM2, ABCC13, S100A12, C2orf88, TMLHE, BMP2K, SAMD4B, LY96, TCN1, AEBP1, HIST1H2AH, DDX60L, HEMK1, LCN2, DOK7, CLCF1, MBOAT2, NDUFAF4, CEACAM6, SERPING1, PBX1, GATSL2, OLIG1, CD79B, TCL1A, PLSCR1, PF4V1, ZNF438, NMU, SUCNR1, DEFA4, GUSBP3, SWAP70, HCAR3, HBD, CDHR3, MIAT, LGALSL, PCGF5, ERV3-2, ZC3H12D, ZNF451, CREG1, IFIT1, LTF, TGFA, LNX2, ABLIM3, CLIC2, SULT1B1, IFI44, PIK3IP1, NT5C1A, CD274, TXN, EFCAB2, PTGR1, DEFA3, NSUN3, PFKFB3, PPP1R3B, ABCA1, GK, ERI1, TSTA3, NBN, IL18R1, CEACAM1, CARD17, USP12, LINC01232, MS4A3, MCTP2, EPSTI1, NAIP, ANKRD22, CSTA, LOXL1, SORT1, CLEC1B, SLC4A1, ZAK, WNK1, AIM2, RRAGD, COL17A1, BEX1, FLVCR2, TFDP2, YOD1, NAPG, CEACAM8, FAS, PRRG4, ABCC4, PAGE2B, MAPK14, HPR, STOM, PLA2G4A, MPO, TLR8, ADAM9, CAMP, QPCT, SIRPD, POLB, PSTPIP2, CCRL2, CD59, CTSG, and AP5B1 |
| Downregulated | ZNF683, FAM193B, DIS3L2, SPIB, GUSBP4, EVL, CD22, PAXBP1, LIG1, SFI1, AQP3, FAM102A, TNFRSF25, HNRNPA0, GUSBP1, FCGBP, WNT3, RYR1, GTF3C3, AES, ITPR3, CRIP3, TCF7, MFSD4B, LOC105370792, MIR600HG, FAM129C, BLK, SMG1P5, PIK3C2B, SMARCA4, GNG7, HIP1R, PLCG1, LOC100132363, POU2AF1, STMN3, ARL4C, FABP3, USP45, SUN2, DMRTC1, CXCR5, EPPK1, MAGED4B, and SNX29P2 |
DEGs, differentially expressed genes; TB, tuberculosis
Differentially expressed miRNA between the normal people and patients with TB.
| Regulation |
| name |
|---|---|---|
| Upregulated | 0 | |
| Downregulated | 2 | miRNA-7 miRNA-451 |
Figure 3The gene ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway enrichment analysis of differentially expressed genes. The biological process (BP), bellular component (CC), and molecular function (MF) consist of GO enrichment analysis commonly. (a) The enrichment dot bubble of GO-BP analysis, (b) the enrichment dot bubble of GO-CC analysis, and (c) the enrichment dot bubble of GO-MF analysis derived from downregulated DEGs. (d) The enrichment dot bubble of GO analysis derived from upregulated DEGs. (e) The enrichment dot bubble of KEGG analysis derived from DEGs.
Gene ontology analysis of common upregulated and downregulated DEGs.
| Category | Term | Count | Gene ratio |
|
|---|---|---|---|---|
|
| ||||
| CC | GO:0016528∼sarcoplasm | 3 | 8.33 | 4.14 |
|
| ||||
| BP | GO:0002446∼neutrophil-mediated immunity | 24 | 2.07 | 3.68 |
| BP | GO:0042119∼neutrophil activation | 24 | 2.07 | 3.85 |
| BP | GO:0043312∼neutrophil degranulation | 23 | 1.98 | 2.01 |
| BP | GO:0002283∼neutrophil activation involved in immune response | 23 | 1.98E-01 | 2.29 |
| BP | GO:0032496∼response to lipopolysaccharide | 13 | 1.12 | 1.08 |
| BP | GO:0002237∼response to a molecule of bacterial origin | 13 | 1.12 | 2.14 |
| BP | GO:0042742∼defense response to a bacterium | 12 | 1.03 | 1.41 |
| BP | GO:0002831∼regulation of response to a biotic stimulus | 12 | 1.03 | 1.08 |
| BP | GO:0006959∼humoral immune response | 11 | 9.48 | 2.28 |
| BP | GO:1903793∼positive regulation of anion transport | 11 | 9.48 | 1.77 |
| MF | GO:0004869∼cysteine-type endopeptidase inhibitor activity | 5 | 4.10 | 3.50 |
| MF | GO:0001618∼virus receptor activity | 5 | 4.10 | 1.52 |
| MF | GO:0140272∼exogenous protein binding | 5 | 4.10 | 1.62 |
| CC | GO:0042581∼specific granule | 16 | 1.32 | 3.31 |
| CC | GO:0070820∼tertiary granule | 13 | 1.07 | 2.88 |
| CC | GO:0034774∼secretory granule lumen | 14 | 1.16 | 1.29 |
| CC | GO:0060205∼cytoplasmic vesicle lumen | 14 | 1.16 | 1.51 |
| CC | GO:0031983∼vesicle lumen | 14 | 1.16 | 1.63 |
| CC | GO:0030667∼secretory granule membrane | 13 | 1.07 | 5.56 |
| CC | GO:0035579∼specific granule membrane | 8 | 6.61 | 9.55 |
| CC | GO:0035580∼specific granule lumen | 7 | 5.79 | 1.09 |
| CC | GO:0070821∼tertiary granule membrane | 7 | 5.79 | 3.43 |
| CC | GO:0005766∼primary lysosome | 8 | 6.61 | 5.56 |
| CC | GO:0042582∼azurophil granule | 8 | 6.61 | 5.56 |
GO, Gene Ontology; DEGs, differentially expressed genes; BP, biological process; CC, cellular component; MF, molecular function; Count, number of DEGs.
KEGG pathway analysis of common upregulated DEGs.
| Pathway | Id | Count | Fold enrichment |
| Genes |
|---|---|---|---|---|---|
|
| |||||
| Hepatocellular carcinoma | hsa05225 | 4 | 12.846 | 2.05 | WNT3, TCF7, SMARCA4, and PLCG1 |
| Kaposi sarcoma-associated herpesvirus infection | hsa05167 | 4 | 11.124 | 3.55 | ITPR3,TCF7,GNG7, and PLCG1 |
| Phosphatidylinositol signalling system | hsa04070 | 3 | 16.687 | 6.84 | ITPR3, PIK3C2B, and PLCG1 |
| Circadian entrainment | hsa04713 | 3 | 16.687 | 6.84 | RYR1, ITPR3, and GNG7 |
| Apelin signaling pathway | hsa04371 | 3 | 11.729 | 1.90 | RYR1, ITPR3, and GNG7 |
KEGG, Kyoto Encyclopedia of Genes and Genomes; DEGs, differentially expressed genes; Count, number of DEGs.
Figure 4(a) Circular nodes show the DEGs. The blue nodes stand for downregulated DEGs, and red nodes stand for upregulated DEGs. (b) The 10 hub genes identified from the PPI network. (c) The top module extracted from the PPI network. The blue nodes stand for downregulated DEGs, and red nodes stand for upregulated DEGs.
Figure 5(a) VENN diagram identified the consistent genes between the DEGs and the target genes of miRNA-7. (b) VENN diagram identified the consistent genes between the DEGs and the target genes of miRNA-451.
Figure 6The PPI network of DEGs and DE miRNA. The blue nodes indicate the downregulated genes. The red nodes indicated the upregulated genes. The blue V-shape nodes stand for downregulated miRNA.